Annual Current Liabilities
$30.35 B
+$5.16 B+20.48%
December 31, 2024
Summary
- As of February 7, 2025, NVO annual total current liabilities is $30.35 billion, with the most recent change of +$5.16 billion (+20.48%) on December 31, 2024.
- During the last 3 years, NVO annual current liabilities has risen by +$15.20 billion (+100.32%).
- NVO annual current liabilities is now at all-time high.
Performance
NVO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$30.35 B
-$859.42 M-2.75%
December 31, 2024
Summary
- As of February 7, 2025, NVO quarterly total current liabilities is $30.35 billion, with the most recent change of -$859.42 million (-2.75%) on December 31, 2024.
- Over the past year, NVO quarterly current liabilities has increased by +$3.37 billion (+12.51%).
- NVO quarterly current liabilities is now -2.75% below its all-time high of $31.21 billion, reached on September 30, 2024.
Performance
NVO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NVO Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.5% | +12.5% |
| 3 y3 years | +100.3% | +100.3% |
| 5 y5 years | +243.2% | +243.2% |
NVO Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +100.3% | -2.8% | +111.5% |
| 5 y | 5-year | at high | +243.2% | -2.8% | +243.2% |
| alltime | all time | at high | >+9999.0% | -2.8% | >+9999.0% |
Novo Nordisk A/S Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $30.35 B(+20.5%) | $30.35 B(-2.8%) |
| Sep 2024 | - | $31.21 B(+15.7%) |
| Jun 2024 | - | $26.97 B(+12.6%) |
| Mar 2024 | - | $23.96 B(-4.9%) |
| Dec 2023 | $25.19 B(+44.7%) | $25.19 B(+3.1%) |
| Sep 2023 | - | $24.44 B(+6.9%) |
| Jun 2023 | - | $22.86 B(+18.3%) |
| Mar 2023 | - | $19.32 B(+11.0%) |
| Dec 2022 | $17.41 B(+14.9%) | $17.41 B(+1.1%) |
| Sep 2022 | - | $17.22 B(+11.8%) |
| Jun 2022 | - | $15.40 B(+7.3%) |
| Mar 2022 | - | $14.35 B(-5.3%) |
| Dec 2021 | $15.15 B(+30.4%) | $15.15 B(+9.9%) |
| Sep 2021 | - | $13.78 B(+18.3%) |
| Jun 2021 | - | $11.65 B(+2.1%) |
| Mar 2021 | - | $11.41 B(-1.8%) |
| Dec 2020 | $11.62 B(+31.3%) | $11.62 B(+3.8%) |
| Sep 2020 | - | $11.19 B(+10.2%) |
| Jun 2020 | - | $10.15 B(+8.8%) |
| Mar 2020 | - | $9.33 B(+5.5%) |
| Dec 2019 | $8.84 B(+6.6%) | $8.84 B(-4.3%) |
| Sep 2019 | - | $9.24 B(+7.2%) |
| Jun 2019 | - | $8.62 B(+4.8%) |
| Mar 2019 | - | $8.23 B(-0.8%) |
| Dec 2018 | $8.30 B(+9.4%) | $8.30 B(+7.9%) |
| Sep 2018 | - | $7.69 B(+0.8%) |
| Jun 2018 | - | $7.63 B(+4.5%) |
| Mar 2018 | - | $7.30 B(-3.7%) |
| Dec 2017 | $7.58 B(+12.4%) | $7.58 B(+6.2%) |
| Sep 2017 | - | $7.14 B(+6.0%) |
| Jun 2017 | - | $6.74 B(-4.0%) |
| Mar 2017 | - | $7.02 B(+4.1%) |
| Dec 2016 | $6.75 B(+12.7%) | $6.75 B(+7.8%) |
| Sep 2016 | - | $6.26 B(+0.8%) |
| Jun 2016 | - | $6.21 B(-0.6%) |
| Mar 2016 | - | $6.24 B(+4.3%) |
| Dec 2015 | $5.99 B(+8.8%) | $5.99 B(+3.0%) |
| Sep 2015 | - | $5.81 B(+0.2%) |
| Jun 2015 | - | $5.80 B(-4.7%) |
| Mar 2015 | - | $6.09 B(+10.7%) |
| Dec 2014 | $5.50 B(+22.7%) | $5.50 B(+7.4%) |
| Sep 2014 | - | $5.12 B(+17.8%) |
| Jun 2014 | - | $4.34 B(-10.6%) |
| Mar 2014 | - | $4.86 B(+8.4%) |
| Dec 2013 | $4.48 B(+16.9%) | $4.48 B(-3.4%) |
| Sep 2013 | - | $4.64 B(+4.5%) |
| Jun 2013 | - | $4.44 B(+0.8%) |
| Mar 2013 | - | $4.40 B(+14.8%) |
| Dec 2012 | $3.84 B(+5.9%) | $3.84 B(-15.5%) |
| Sep 2012 | - | $4.54 B(+13.8%) |
| Jun 2012 | - | $3.99 B(+1.4%) |
| Mar 2012 | - | $3.94 B(+8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $3.62 B(+9.9%) | $3.62 B(-2.5%) |
| Sep 2011 | - | $3.71 B(+2.9%) |
| Jun 2011 | - | $3.61 B(+4.5%) |
| Mar 2011 | - | $3.46 B(+4.8%) |
| Dec 2010 | $3.30 B(+27.7%) | $3.30 B(+6.5%) |
| Sep 2010 | - | $3.09 B(+3.1%) |
| Jun 2010 | - | $3.00 B(+6.6%) |
| Mar 2010 | - | $2.82 B(+9.1%) |
| Dec 2009 | $2.58 B(+5.9%) | $2.58 B(+1.4%) |
| Sep 2009 | - | $2.54 B(+8.2%) |
| Jun 2009 | - | $2.35 B(-6.5%) |
| Mar 2009 | - | $2.51 B(+3.1%) |
| Dec 2008 | $2.44 B(+16.9%) | $2.44 B(+4.9%) |
| Sep 2008 | - | $2.32 B(-0.2%) |
| Jun 2008 | - | $2.33 B(-4.9%) |
| Mar 2008 | - | $2.45 B(+17.4%) |
| Dec 2007 | $2.08 B(+16.0%) | $2.08 B(+1.2%) |
| Sep 2007 | - | $2.06 B(+7.4%) |
| Jun 2007 | - | $1.92 B(+0.5%) |
| Mar 2007 | - | $1.91 B(+6.2%) |
| Dec 2006 | $1.80 B(+7.2%) | $1.80 B(-8.0%) |
| Sep 2006 | - | $1.95 B(+11.6%) |
| Jun 2006 | - | $1.75 B(+2.7%) |
| Mar 2006 | - | $1.71 B(+1.7%) |
| Dec 2005 | $1.68 B(+25.6%) | $1.68 B(+11.6%) |
| Sep 2005 | - | $1.50 B(+3.6%) |
| Jun 2005 | - | $1.45 B(+11.7%) |
| Mar 2005 | - | $1.30 B(-2.8%) |
| Dec 2004 | $1.33 B(+18.7%) | $1.33 B(+9.9%) |
| Sep 2004 | - | $1.21 B(+10.9%) |
| Jun 2004 | - | $1.09 B(-4.6%) |
| Mar 2004 | - | $1.15 B(+2.1%) |
| Dec 2003 | $1.12 B(+33.6%) | $1.12 B(+33.6%) |
| Dec 2002 | $841.27 M(+18.5%) | $841.27 M(+18.5%) |
| Dec 2001 | $709.85 M(-11.3%) | $709.85 M(-11.3%) |
| Dec 2000 | $800.07 M(+5.1%) | $800.07 M(+5.1%) |
| Dec 1999 | $761.33 M(-11.4%) | $761.33 M(-11.4%) |
| Dec 1998 | $858.95 M(+10.2%) | $858.95 M(+10.2%) |
| Dec 1997 | $779.56 M(-5.6%) | $779.56 M(-5.6%) |
| Dec 1996 | $825.71 M(+16.4%) | $825.71 M(+16.4%) |
| Dec 1995 | $709.25 M(-5.8%) | $709.25 M(-5.8%) |
| Dec 1994 | $752.74 M(+38.1%) | $752.74 M(+38.1%) |
| Dec 1993 | $545.20 M(-0.4%) | $545.20 M(-0.4%) |
| Dec 1992 | $547.28 M(-16.1%) | $547.28 M(-16.1%) |
| Dec 1991 | $652.11 M(-9.5%) | $652.11 M(-9.5%) |
| Dec 1990 | $720.85 M(+30.8%) | $720.85 M(+30.8%) |
| Dec 1989 | $551.25 M(+39.1%) | $551.25 M(+39.1%) |
| Dec 1988 | $396.36 M(+14.2%) | $396.36 M(+14.2%) |
| Dec 1987 | $347.05 M(+16.2%) | $347.05 M(+16.2%) |
| Dec 1986 | $298.79 M(+67.2%) | $298.79 M(+67.2%) |
| Dec 1985 | $178.69 M(+7.8%) | $178.69 M(+7.8%) |
| Dec 1984 | $165.83 M | $165.83 M |
FAQ
- What is Novo Nordisk A/S annual total current liabilities?
- What is the all time high annual current liabilities for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual current liabilities year-on-year change?
- What is Novo Nordisk A/S quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly current liabilities year-on-year change?
What is Novo Nordisk A/S annual total current liabilities?
The current annual current liabilities of NVO is $30.35 B
What is the all time high annual current liabilities for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual total current liabilities is $30.35 B
What is Novo Nordisk A/S annual current liabilities year-on-year change?
Over the past year, NVO annual total current liabilities has changed by +$5.16 B (+20.48%)
What is Novo Nordisk A/S quarterly total current liabilities?
The current quarterly current liabilities of NVO is $30.35 B
What is the all time high quarterly current liabilities for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly total current liabilities is $31.21 B
What is Novo Nordisk A/S quarterly current liabilities year-on-year change?
Over the past year, NVO quarterly total current liabilities has changed by +$3.37 B (+12.51%)